Publikationen in Zusammenarbeit mit Forschern von University of Texas MD Anderson Cancer Center (17)

2023

  1. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies

    The Lancet. Public health, Vol. 8, Núm. 9, pp. e691-e700

2022

  1. Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

    Cancer Epidemiology Biomarkers and Prevention, Vol. 31, Núm. 3, pp. 679-687

2021

  1. Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis

    Cancer Chemotherapy and Pharmacology, Vol. 87, Núm. 1, pp. 113-124

2020

  1. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer

    Cells, Vol. 9, Núm. 5

  2. Design, reliability and construct validity of a Knowledge, Attitude and Practice questionnaire on personal use of antibiotics in Spain

    Scientific Reports, Vol. 10, Núm. 1

  3. Mediational mechanisms involved in the relation between attachment insecurity and depression: A meta-analysis

    Journal of Affective Disorders, Vol. 277, pp. 706-726

2019

  1. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

    Nature Communications

  2. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region

    Journal of Thoracic Oncology, Vol. 14, Núm. 8, pp. 1360-1369

2018

  1. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

    Nature Communications, Vol. 9, Núm. 1

  2. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Association analysis identifies 65 new breast cancer risk loci

    Nature, Vol. 551, Núm. 7678, pp. 92-94

2016

  1. Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients

    Acta Haematologica, Vol. 136, Núm. 2, pp. 76-84

2013

  1. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

    Nature Genetics, Vol. 45, Núm. 8, pp. 868-876

  2. Hypothesized role of pregnancy hormones on HER2+ breast tumor development

    Breast Cancer Research and Treatment, Vol. 137, Núm. 1, pp. 237-246

2008

  1. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: A HuGE-GSEC review

    Genetics in Medicine, Vol. 10, Núm. 6, pp. 369-384

2006

  1. Meta- and pooled analysis of GSTT1 and lung cancer: A HuGE-GSEC review

    American Journal of Epidemiology, Vol. 164, Núm. 11, pp. 1027-1042

2005

  1. Metabolic gene polymorphisms and lung cancer risk in non-smokers: An update of the GSEC study

    Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis